JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

688076

CNE1000051X5

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
56.89 ^CNY	+0.16%		+0.57%	+26.56%

May. 21	Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	CI
Apr. 22	Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.

June 07, 2023

Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (SHSE:688076) from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million on June 7, 2023.

Latest news about Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2024.	May. 20	CI
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 22	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 23	CI
Sinopep-Allsino Biopharmaceutical's Raw Drug Material Gets OK to Submit Drug Application to US FDA; Shares Up 4%	Dec. 19	MT
Sinopep-Allsino Biopharmaceutical Gets Nod to Issue Convertible Bonds	Nov. 17	MT
Sinopep-Allsino’s Hypertension Drug Shortlisted for China’s Drug Procurement Program	Nov. 08	MT
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(XSSC:688076) added to S&P Global BMI Index	23-09-18	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.	23-06-07	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. announced that it expects to receive CNY 300 million in funding	23-04-20	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-18	CI
Sinopep-Allsino Biopharma Unit to Buy 9% Stake in Biotech Firm	22-09-28	MT
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Zhejiang Zhongcheng Pharmaceutical Co., Ltd. agreed to acquire 45% stake in Hangzhou Xinbosi Biopharmaceutical Co., Ltd. from Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. for CNY 13.5 million.	22-06-29	CI
Certain A Shares of Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. are subject to a Lock-Up Agreement Ending on 21-MAY-2022.	22-05-20	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange Composite Index	22-05-20	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.(SHSE:688076) added to Shanghai Stock Exchange A Share Index	22-05-20	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-27	CI
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-25	CI

Chart Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Duration

Period

Chart Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

More charts

Company Profile

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd a China-based company principally engaged in the independent research and development and customized research and development and production of peptide drugs and small molecule drugs. The Company's main business includes customized product business and independently selected product business. Its customized product business includes CDMO (Contract Development and Manufacturing Organization) business, technical service CRO (Contract Research Organization) and transfer business. Its independently selected product business focuses on small molecule chemical drugs and conducts drug research and development in the key treatment areas of diabetes, cardiovascular diseases, tumors and other diseases. The Company mainly operates its businesses in the domestic market and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

56.89 CNY

Average target price

62.24 CNY

Spread / Average Target

+9.41%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL CO., LTD.	+26.56%	1.67B
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B
PFIZER, INC.	-0.45%	162B

Other Pharmaceuticals

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Equities

688076

CNE1000051X5

Pharmaceuticals

Jiande Xinglian Enterprise Management Co., Ltd. entered into an agreement to acquire 4.84% in Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from Jiande Wuxing Biological Technology Co., Ltd. for CNY 369 million.

Latest news about Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Chart Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

Ratings for Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Pharmaceuticals